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1. Introduction 
Ceramic materials are made of an inorganic non-metallic oxide. Usually ceramics are 
divided into two groups: silicon ceramics and aluminous ceramics. Ceramics are also 
divided into crystalline and non-crystalline depending on inner molecular organization. 
Depending on their in vivo behaviour, ceramics are classified as bioresorbable, bioreactive or 
bioinert. Alumina and zirconia are bioinert ceramics; their low reactivity togheter with their 
good mechanical features (low wear and high stability) led to use them in many biomedical 
restorative devices. Their most popular application  is in arthroprosthetic joints where they 
have proven to be very effective, that make their use suitable especially in younger, more 
active patients. Also dental use of these materials was proposed to achieve aesthetic and 
reliability of dental restorations.   
2. Mechanical and chemical features of bioceramics 
2.1 Alumina 
Corundum known as α-alumina is the alumina ceramic used for biomedical application,. In 
nature single crystals of this material are known as ruby if containing Cr2O3 impurities, or 
as sapphire if containing titanium impurities which give them blue colour. Al2O3 molecule is 
one of the most stable oxides because of high energetic ionic and covalent bonds between Al 
and O atoms. These strong bonds (Alumina DG(298K) =1580 KJ/mol) leave the ceramic 
unaffected by galvanic reactions (absence of corrosion, e.g. absence of ion release from bulk 
materials and from wear debris).  Adverse conditions such as strong acidic or alkaline 
environment at high temperatures didn’t corrupt allumina properties. Under compression 
allumina showed good resistance but under tensile strength shows its brittleness. at room 
temperature alumina does not show plastic deformation before fracture (e.g. no yield point 
in stress-strain curve before fracture), and once started fractures progress very rapidly (low 
toughness KIC). 
Tensile strength of alumina improves with higher density and smaller grain size. A careful 
selection of raw materials and a strict control of production process are performed by 
manufacturers to optimize allumina mechanical properties. Introduction of low melting 
MgO in the ceramic process enhanced mass transport during solid state sintering so that 
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ceramic reached full density at lower temperature. Moreover decreasing grain growth a 
stronger ceramic was obtained. 
Additions of small amounts of Chromia (Cr2O3) compensated the reduction of hardness 
subsequent to the introduction of MgO. CaO content in medical grade alumina devices must 
be reduced since in wet environment it can compromise its mechanical properties.  NaOH 
impurities in powders obtained by the Bayer process makes allumina unsuitable for the hi-
tech biomedical application. Continuous efforts to improve the properties of alumina 
bioceramics are being made, e.g. by the introduction of high purity raw materials, hot 
isostatic pressing, proof testing on 100% of manufactured components. The use of hot 
isostatic pressing (HIP) in bioceramics production minimizes the residual stresses within 
ceramic pieces and gives ceramics with density close to the theoretical one, improving the 
strength and reliability of the product. Proof testing of Allumina components consists in the 
application of internal pressure inducing a stress close to the maximum load bearing 
capability; when applied to 100% of the parts manufactured, defective products can be 
eliminated before final inspection. The introduction of laser marking contributed to 
components traceability due improving the overall quality of the manufacturing process  
In 1930 for the first time allumina was used as a biomaterial with the first patent applied by 
Rock in Germany. Sandhaus in 1965 patented a screw-shaped dental implant made of high 
alumina powder Degussit AL23. This was the first step in a new era in ceramic engineering. 
A new dental implant , step-shaped, followed  the screw shaped, and was named Tübingen 
type. But only with the use in orthopaedic purpose in 1970 by Boutin, Allumina was 
worldwide diffused. He implanted successfully first allumina joints since 1970. Nowadays 
more than 3 million alumina ball heads have been implanted worldwide. Today, almost 50% 
of hip arthroplasties performed in Central Europe make use of ceramic ball heads. 
2.2 Zirconia 
Zirconia, the metal dioxide  of zirconium (ZrO2), was used for a long time as pigment for 
ceramics; it  was identified in 1789 by the German chemist Martin Heinrich Klaproth. 
To stabilize zirconium oxide a little amount of non-metallic oxide were added (such as 
MgO, CaO and Y2O3); at a first time magnesia- partially stabilized zirconia (MgPSZ) was the 
most studied ones, in which a tetragonal phase is present as small acicular precipitates 
within large cubic grains (Ø40÷50 μm) forming the matrix. But wear properties were badly 
influenced by  this feature; most of the developments were focused on yttria stabilized 
tetragonal zirconia polycrystal (Y-TZP), a ceramic completely formed by submicron-sized 
grains, which is today the standard material for clinical applications. Tetragonal grains in  Y-
TZP ale smaller than 0.5 μm. Tetragonal phase rate retained at room temperature is 
influenced by: - grains size and on its homogeneous distribution; - the concentration of the 
yttria stabilizing oxide; - the constraint exerted by the matrix onto grains. The equilibrium 
among such microstructural parameters  influences mechanical features of Y-TZP ceramics. 
Tetragonal grains can transform in monoclinic, with a 3-4% volume growth of grains: this is 
the origin of the toughness of the material, e.g. of its ability to dissipate fracture energy. 
When the pressure on the grains is relieved, i.e. by a crack advancing in the material, the 
grains near the crack tip shift into monoclinic phase. This gives origin to increased 
toughness, because the energy of the advancing crack is dissipated at the crack tip in two 
ways, the first one due to the T-M transformation, the second one due to the need of the 
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In wet environments, over 100°C, tetragonal phase of zirconia ceramics can spontaneously 
transform into monoclinic. Because this phenomenon starts from the surface of the material, 
it is possible to report a loss of material density and  a reduction in strength and toughness 
of zirconia. This degradation goes under the name of “ageing” and is due to the progressive 
spontaneous transformation of the metastable tetragonal phase into the monoclinic phase. 
Spontaneous T-M transformation in TZP is probably due to the formation of zirconium 
hydroxides or yttrium hydroxides that promoted phase transition for local stress 
concentration or variation of the yttrium/zirconium ratio 
Swab summarized  main steps of TZP ageing in the following way: 
The most critical temperature range is 200-300°C. 
The effects of ageing are the reduction in strength, toughness and density, and an increase in 
monoclinic phase content. 
Degradation of mechanical properties is due to the T-M transition, taking place with micro 
and macro-cracking of the material. 
T-M transition starts on the surface and progresses into the material bulk. 
Reduction in grain size and/or increase in concentration of stabilising oxide reduce the 
transformation rate. 
T-M transformation is enhanced in water or in vapour. 
Strength degradation rate is not the same for all TZP ceramics. Swab  described that  in ten 
materials tested in presence of water vapour at low temperature, different levels of strength 
degradation occurred in all the materials but one, where strength remained the same after 
the treatment. The differences in equilibrium of microstructural parameters like yttria 
concentration and distribution, grain size, flaw population and distribution in the samples 
tested  caused this variability in ageing behaviour. Strength degradation rate can be 
controlled by having a high density, small and uniform grain size, a spatial gradient of yttria 
concentration within grains, introduction of alumina into the matrix. All the above 
parameters are controlled by the manufacturing process and by the chemical-physic 
behaviour of the precursors selected for the production of the ceramic. These facts make 
stability a characteristic of each Y-TZP material and of each manufacturing process. 
Hydrothermal treatment has an high risk of phase transition: steam sterilization of zirconia 
ball heads is not recommended. These process may change the surface finish, reducing wear 
resistance. Nevertheless, mechanical properties of the material are not altered by these 
process. Gamma rays or ethylene oxide sterilization are the best choice to manage zirconia 
biomedical devices. Rare hearth impurities that may be present at part per million (ppm) 
level within the structure can interact with ionising radiation inducing some changes in 
colour in ceramic materials. Praseodymium impurities cause a shift to violet of zirconia after 
irradiation, but the material can return to its ivory colour with heating and putting it under 
an intense light source; its mechanical properties weren’t unaffected by this treatment. 
At room temperature Y-TZP ceramic is formed by submicron size grain. during sintering the 
grains will grow and it is necessary to start from submicron grain size powders and to 
introduce some sintering aid to limit the phenomenon. The introduction of the stabilizing 
oxide (yttria Y2O3) is a key component in TZP structure at room temperature. hydrothermal 
stability of the ceramic is enhanced by enriching  grain boundaries in yttria: ZrO2 grains 
may be yttria coated as in plasma, an alternative to obtain Y-TZP powders by co-
precipitation. silica impurities must be avoided because the dissolution of glassy phases at 
the grain boundaries in wet environment causes the spontaneous transformation of the 
grains from tetragonal to monoclinic with a loss of mechanical properties.  To achieve an 
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equilibrium  a higher toughness and hydrothermal stability must be balanced by a lower 
bending strength 
2.3 Zirconia toughened alumina  
Zirconia toughened alumina (ZTA) is obtained adding zirconia up to 25% wt into an 
alumina matrix. This allow to obtain a class of ceramic materials with increased toughness. 
These materials, developed in the second half of the seventies are featured by toughness 
(KIC) up to 12 MPam-1/2 and bending strength up to 700 MPa. Alumina matrix exerts a 
constraint on the metastable tetragonal zirconia particles maintaining them in the tetragonal 
state. T-M transformation of the zirconia particles give toughness to this ceramic. Because of 
different elastic modulus between alumina matrix and the zirconia particles cracks are 
propagated along zirconia crystals inducing their T-M phase transformation thus 
dissipating the crack energy. Microcracking of the matrix due to the expansion of the 
dispersed particles is a further dissipative effect. To ensure the better mechanical 
performances to this material is mandatory to control the high density of the matrix and the 
optimisation of the microstructure of the zirconia particles. In this way the maximum 
amount of metastable phase is retained assuring the transformation of the maximum 
volume. When hardness is of paramount importance ZTA have some drawbacks: zirconia 
into the hard alumina matrix results in a decrease in hardness of the ceramic Extensive 
research has been focussed on ZTA in France and in Italy on ceramics containing up to 80% 
zirconia, without leading to clinical applications. Allumina can also be toughened by 
addition of whiskers; but concerns about carcinogenicity of whiskers, and limits in adhesion 
of the whiskers to the matrix decreased the interest for the biomedical applications of these 
materials. Elongated grains (platelets), acting as whiskers, can be nucleated within the 
structure of a ZTA ceramic. This can be obtained by adding e.g. strontium oxide (SrO) to 
ZTA obtaining SrAl12O19platelets by in situ solid state reaction during sintering. Chromia 
(Cr2O3), introduced to save the alumina hardness and of Yttria (Y2O3) that acts as stabilizer 
of the T phase of zirconia in ZTA, leads to a material known as ZPTA(Zirconia Platelet 
Toughened Alumina) The resulting mechanical properties are very interesting, as wear rates 
were very low in the laboratory tests, even lower than the ones of alumina and zirconia both 
on hip and knee simulator studies 
ZPTA is a great innovation in ceramic for biomedical devices. Mechanical properties of this 
new ceramic, allow to develop many innovative ceramic devices. 
 
Property Unit Allumina Y-TZP ZTA ZPTA 
Density g/cm2 3.98 6.08 5.00 4.36 
Average grain size µm ≤1.8 0.3÷0.5 - - 
Bending strength MPa >550 1200 900 1150 
Compression strenght MPa 5000 2200 2900 4700 
Young modulus GPa 380 200 285 350 
Fracture toughness KIC Mpam-1/2 4-5 9 6.9 8.5 
Microhardness HV 2200 1000-1300 1500 1975 
 
Table 1. Selected Properties of load bearing bioceramics for medical devices  
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Biocompatibility has been defined as “the ability of a material to perform with an 
appropriate host response in a specific application”. Reaction of bone, soft collagenous 
tissues and blood are involved in the host response to ceramic implants. Interfacial 
reaction between these materials and body tissues both in vitro and in vivo must be 
considered evaluating biocompatibility of bioinert ceramics. Low rate of tissue reactions  
towards Alumina are the reason because it is often considered reference in testing 
orthopaedic ceramic biomaterials. The first experimental data of dense ceramics (ZrO2) in 
vivo biocompatibility in orthopaedic surgery were published 1969 by Helmer and Driskell 
while the first clinical cases on alumina were described later by Boutin shortly followed 
by Griss. In vitro biocompatibility evaluation of Alumina and Zirconia were performed 
later than their clinical use. As biocompatibility tests often are reporting the comparison 
of alumina and zirconia biocompatibility, in the following the results are reviewed in the 
same manner. 
3.1 In vitro tests 
Ceramic materials in different physical forms (powders and dense ceramics) were used to 
perform in vitro tests on cell cultures. Absence of acute toxic effects of ceramic in powder 
and disk form on the different cell lines used in tests both towards allumina both toward 
zirconia was reported by many studies. In vitro assays are influenced  by material 
characteristics, such as the physical form, reactive surface, chemical composition, impurity 
content etc, as well as by the cell conditions during the tests. Alumina and zirconia disks 
with 30% of porosity allow adhesion and spreading of 3T3 fibroblasts as observed using 
SEM. HUVEC and 3T3 fibroblasts osteoblast didn’t show any toxic reaction toward Al2O3  
or ZrO2 samples (MTT test on cells direct in contact with ceramic particles); the same effects 
were also observed on ceramic extracts cocultured with fibroblasts. Li, et al demonstrated 
that powders were more toxic than dense ceramics, using direct contact tests and MTT test 
with human oral fibroblasts. Ceramic powders can induce apoptosis in macrophages 
depending on materials concentration as observed by Catelas. Mebouta, et al reported for 
the first time a different toxic effect between alumina and zirconia: in particular a higher 
cytotoxicity of alumina particles in comparison to the zirconia ones was measured as human 
monocytes differentiation; this is probably due to the higher reactive surface of the alumina 
particles, that were significantly smaller than the zirconia ones 
Degidi compared soft tissues reactions to ZrO2 and titanium; he reported that inflammatory 
infiltrate, microvessel density and vascular endothelial growth factor expression appeared 
higher around titanium samples than around ZrO2 ones. Moreover  cellular proliferation on 
zirconia surface is higher than on titanium ones. Furthermore Warashima reported less 
proinflammatory mediators(IL-1, IL-6 and TNF generated by ZrO2 than titanium or 
polyethylene. 
3.2 In vivo tests 
Different physical forms and in different sites of implantation were evaluated in order to 
analyzing systemic toxicity, adverse reactions of ceramics in soft tissue and/or bone The 
work of Helmer and Driskell already cited is the first report of implant in bone of zirconia. 
Pellets were implanted into the monkey’s femur, the Authors observed an apparent bone 
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ingrowth without any adverse tissue reaction. Hulbert, et al implantated of porous and non 
porous disks and tubes in the paraspinal muscles of different ceramics Authors observed 
ingrowth depending on porous size, and no signs of systemic toxicity. After subcutis, 
intramuscular or intraperitoneal and intraarticular introduction of alumina and zirconia 
powders in rats and/or mice mant authors reported the absence of acute systemic adverse 
tissue reactions to ceramics; similar results were reported after implantation of bars or pins 
to paraspinal muscles of rabbits or rats and after insertion in bone.  bone ceramic interface  
showed connective tissue presence, progressively transformed in bone direct contact with 
ceramic. Bortz reported adverse tissue reaction: fibrous tissue in the lumen of zirconia 
cylinders implanted in dogs and rabbits trachea, and an inflammatory reaction against 
ceramic powders inserted on PMMA grooves implanted in rabbits femur. In any case this 
inflammatory reaction was lower than the one observed against CoCr and UHMWPE. 
3.3 Carcinogenicity 
Griss, et al. in 1973 reported that Alumina and zirconia powders did not induce tumours. 
They analyzed the long term in vivo reactions to ceramics. 
Ames test, and carcinogenicic or mutagenic tests used to study zirconia dishes confirmed 
that this bioceramic did not elicit any mutagenic effect in vitro. Moreover zirconia 
radioactivity and its possible carcinogenic effect was also evaluated: radioactivity of the 
powder is depending on the source of ores used in the production of the chemical precursor 
of the zirconia powders. Only Ryu RK, et al reported a possible carcinogenic effect of 
ceramic. They observed association between ceramic and soft tissue sarcoma. Some recent 
studies have been performed about carcinogenicity of Zirconia Toughened Alumina. 
Maccauro et al. showed that ZPTA as well as Alumina and Zirconia ceramics did not elicit 
any in vitro carcinogenic effects; the same group are going to demonstrate the possible 
carcinogenic in vivo effects of ZPTA. 
4. Biomedical applications of zirconia 
Several comprehensive reviews on the clinical outcomes of ceramic ball heads for 
orthopaedical devices are aviable. Jenny, Caton, Oonishi, Hamadouche, demonstrate the 
favourable behaviour of ceramic biomaterials in reducing the wear of arthroprostheses 
joints.  
 
THR ball heads 






Table 2. Orthopaedic medical devices made of bioinert ceramics 
Clinical trials demonstrated that ceramic-on-ceramic coupling decreased significantly the 
amount of wear debris (Boeler,). Nevertheless Wroblesky demonstrated that ceramic in 
couple with new generation polyethylene may constitute a significant evolution in 
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arthroplasty. This makes ceramics in joints suitable especially in younger patients. The 
matching of surface roughness, roundness and linearity in the coupling of ceramic tapers 
with the metallic trunnion plays a relevant role on stresses distribution and intensity, 
depending also on cone angle, extent of the contact, friction coefficient among the two 
surfaces Mismatch in female- to-male taper, e.g. due to the many angles in clinical use, 
roundness, roughness or linearity errors in the taper, are among the most likely 
“technologic” initiators of ceramic ball head failures. It must be remarked that the 
mechanical behaviour of ceramic ball heads once installed on the metallic taper depend not 
only on the ceramic but  also on material and design of the taper. Besides the “technologic” 
failure initiators, several other precautions are necessary when using ceramic ball heads: 
avoid third body interposition to the ceramic metal, or ceramic/ceramic interface during 
surgery (e.g.blood clots, bone chips, PMMA cement debris); avoid use of metallic mallets 
when positioning ball heads on metallic taper (or of alumina inlay into the metal back): use 
plastic tools provided by the manufacturer or gently push rotate by hand; avoid thermal 
shocks to ball heads (e.g. dip the ceramic in saline to cool it after autoclave sterilization); 
avoid application of new ceramic ball heads onto stems damaged during revision surgery. A 
third important aspect to achieve good arthroprostheses results is surgical technique: both 
perfect THR component adaptation and orientation, together with soft tissue tension are 
required. Special care must be taken with orientation, as edge loading of the socket and 
impingement on components depend on this parameter. 
In the past zirconia was highly used in orthopedics; about 900000 zirconia ball heads have 
been implanted in total hip arthroplasties, even if a debate arose regarding the potential 
radioactivity and carcinogenicity of zirconia source. But, after the observation of some ball 
head fractures, zirconia has no longer been used for total hip arthroplasties. 
Zirconium oxide is also used as a dental restorative material. Inlays, onlays, single crowns, 
fixed partial dentures, can be realized using a ZrO2 core. Moreover, also implant abutment 
and osteointegrated implant for tooth replacement are available in zirconia.  
Realization of dental products requires a preventive project and successive manufacturing 
in order to satisfy clinical requirement. But, not only individualization is needed: accuracy 
is absolutely mandatory. Misfits greater than 50 m are considered unacceptable for 
dental restorations. Mechanical resistance must be also considered. Frameworks with 
minimal thickness, often less than 1mm, must be able to sustain chewing stresses. 
Masticatory load on posterior teeth range from 50N to 250N, while parafunctional 
behavior such as clenching and bruxism can create loads about 500 and 800N. Zirconia 
frameworks can bear load between 800 and 3450N. These values are compatible with 
restorations on posterior teeth if parafunctional loads are not present and a correct 
framework design is performed . 
In order to avoid misfit due to shrinkage during sintering, it is possible to obtain zirconia 
frameworks by milling full-sintered ZrO2 samples. This technique is not influenced by 
sintering problems because zirconia is already sintered, but, anyway, it is influenced by 
operator accuracy in probe use. CAD/CAM technique is the ultimate opportunity in 
managing zirconia dental devices production. CAD/CAM is acronym of Computer Aided 
Design and of Computer Assisted Manufacturing. This system is composed by a digitizing 
machine to collect information about teeth position and shape, appropriate software for 
design zirconia restoration and a computer assisted milling machine that cut from a zirconia 
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sample the desidered framework. This technique reduces human influences allowing 
obtaining greater accuracy in zirconia core production. 
Fully sintered zirconia blocks are very difficult to be grinded. Milling procedures are very 
slow and requires very effective burs to perform cut in the optimal way. Dimensional 
stability is granted because there aren’t any procedures that can influence volume of 
framework after milling. On the other hand, grinding reduces significatively toughness of 
zirconia. This can be due to surfacial stresses during milling. Crystals were induced to 
transform from tetragonal into monocline reducing T-M phases ratio and consequently 
toughness. Lutardth measured flexural strength and fracture toughness of zirconia before 
and after grinding and concluded that mechanical resistance was reduced of about 50% after 
machining. Also Kosmac studying surface grinding effects on ZrO2 confirmed these results. 
Machining partially sintered zirconia (or green zirconia) presents, on the other hand, 
different problematics. Green zirconia has a very soft consistency resulting very easy to be 
milled. Grinding procedures are easy, faster and cheaper. But, after grinding, frameworks 
must be sintered. This procedure presents some technical problems that require accurate 
managing to grant a reliable outcome. During Sintering time (about 11 hours) an accurate 
control of temperature and pressure, especially during cooling phase, is needed to obtain 
the correct T-M crystals ratio. Moreover, sintering lead to a 20% volumetric shrinkage that 
must be foresight in advance during designing and milling. For these reasons use of green 
zirconia results more difficult and expensive: complex designing software and sintering 
machine are required to obtain accuracy and correct crystal composition. On the other side, 
if procedures are preformed correctly mechanical resistance results greater than ZrO2 
frameworks milled after sintering]. Moreover sinterization after grinding allows technician 
also to pigment frameworks helping achieving a satisfying aesthetical outcome.  
Ceramic restorations allow an aesthetical outcome more similar to teeth than conventional 
metal-ceramic ones. Also gingival aesthetic is improved by colour of restoration similar to 
teeth, that is, together with mucosal thickness the basic parameter for an optimal soft tissue 
colour outcome. Toughness and colour similar to teeth of zirconia, lead to use this material 
for different purpose. Zirconiun oxide is used as a reinforce for endocanalar fiber-glass post. 
Also orthodontic brackets were proposed in ZrO2. But the most interesting application of 
this material is nowadays for fixed partial dentures. Single crowns and 3-5 units FPD are 
described and studied in literature. The continuative search for an optimal metal-free 
material for prosthetical use found in zirconia an answer for many problems still not solved 
with other ceramic restorations. Also small dental restorations, like inlays and onlays were 
proposed with this material. Implanto-prothesical components, such as implant abutment 
are available with zirconia. Osteointegrated implants for tooth replacement are proposed by 
some manufacturers, but at the present time there aren’t enough studies about behaviour of 
zirconia implants.  
Zirconia restorations have found their indications for FPDs supported by teeth or implants. 
Single tooth restorations are possible on both anterior and posterior elements because of the 
mechanical reliability of this material. Mechanical resistance of zirconia FPD was studied on 
single tooth restorations and on partial dentures. Luthy asserted that Zirconia core could 
fracture with a 706N load Tinshert reported a fracture loading for ZrO2 over 2000N, Sundh 
measured fracture load between 2700-4100N. Zirconia restorations can reach best results as 
fracture resistance if compared with alumina or lithium disilicate ceramic restorations. 
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Ageing of Zirconia can have detrimental effects on its mechanical properties. To accelerate 
this process mechanical stresses and wetness exposure are critical. Ageing on zirconium 
oxide used for oral rehabilitation is not completely understood. However, an in vitro 
simulation reported that, although ageing the loss of mechanical features does not influence 
resistance under clinical acceptable values. Further evaluations are needed because zirconia 
behavior in long time period is not yet investigated. 
On these basis a new family of ceramic material that would complement alumina ceramic 
where needed. It had to posses the highest possible toughness, the smallest matrix grain size 
all leading towards improved mechanical reliability but this had to be accomplished 
without sacrificing the wear resistance and chemical stability of current day alumina 
ceramics. Alumina Matrix Composites were selected as the best new family of ceramics to 
provide the foundation for an expanded use of ceramics in orthopaedics. The main 
characteristics of this Alumina Matrix Composite are its two toughening mechanisms. One 
is given by in-situ grown platelets which have a hexagonal structure and are 
homogeneously dispersed in the microstructure. Their task is to deflect any sub-critical 
cracks created during the lifetime of the ceramic and to give the entire composite stability. 
The other important characteristic is related to the addition of 17 vol.-% zirconia nano-
particles that are dispersed homogeneously and individually in the alumina matrix. This 
increases strength and toughness of the material to levels equal and in some cases above 
those seen in pure zirconia. Here, the effect of tetragonal to monoclinic phase transformation 
is used as a toughening mechanism. In the case of micro-crack initiation the local stress 
triggers phase transformation at an individual zirconia grain which acts then as an obstacle 
to further crack propagation. It is a desired behaviour which uses the volume expansion in 
an attempt to prevent further crack propagation. These two well known effects in material 
science, crack deflection and transformation toughening give Alumina Matrix Composite a 
unique strength and toughness unattained by any other ceramic material used in a 
structural application in the human body.  
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